Evidence map›Paper›PMID 36831624›Full record

ArticleCancers2023

Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients.

Othman R Alzahrani, Rashid Mir, Hanan E Alatwi, Yousef M Hawsawi, Amnah A Alharbi, Abdulrahman H Alessa, Elham Saleh Albalawi, Imadeldin Elfaki, Yousef Alalawi, Laila Moharam and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Othman R AlzahraniDepartment of Biology, Faculty of Science, University of Tabuk, Tabuk 47512, Saudi Arabia.ORCID 0000-0002-2726-0473
Rashid MirDepartment of Medical Lab Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 47512, Saudi Arabia.
Hanan E AlatwiDepartment of Biology, Faculty of Science, University of Tabuk, Tabuk 47512, Saudi Arabia.
Yousef M HawsawiCollege of Medicine, Al-Faisal University, Takhasusi Road, P.O. Box 50927, Riyadh 11533, Saudi Arabia.ORCID 0000-0003-1901-697X
Amnah A AlharbiGenome and Biotechnology Unit, Faculty of Science, University of Tabuk, Tabuk 47512, Saudi Arabia.ORCID 0000-0001-9879-9508
Abdulrahman H AlessaDepartment of Biology, Faculty of Science, University of Tabuk, Tabuk 47512, Saudi Arabia.
Elham Saleh AlbalawiDepartment of Pathology, Faculty of Medicine, University of Tabuk, Tabuk 47512, Saudi Arabia.
Imadeldin ElfakiGenome and Biotechnology Unit, Faculty of Science, University of Tabuk, Tabuk 47512, Saudi Arabia.
Yousef AlalawiDepartment of Surgery, King Salman Armed Forces Hospital, Tabuk 47512, Saudi Arabia.
Laila MoharamDepartment of Pathology, King Salman Armed Forces Hospital, Tabuk 47512, Saudi Arabia.ORCID 0000-0002-3051-573X
Sabah H El-GhaieshDepartment of Pharmacology, Faculty of Medicine, University of Tabuk, Tabuk 47512, Saudi Arabia.ORCID 0000-0001-7032-528X
University of Tabuk · SAArmed Forces Hospital · SAAlfaisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies have reported link between SNPs and risk of breast cancer. This study investigated the association of the selected gene variants by predicting them as possible target genes. Molecular technique advances with the availability of whole-exome sequencing (WES), now offer opportunities for simultaneous investigations of many genes. The experimental protocol for PI3K, AKT-1, KLF-14, MDM4, miRNAs 27a, and miR-196a genotyping was done by ARMS-PCR and sanger sequencing. The novel and known gene variants were studied by Whole-exome sequencing using Illumina NovaSeq 6000 platform. This case control study reports significant association between BC patients, healthy controls with the polymorphic variants of PI3K C > T, AKT-1 G > A KLF 14 C > T, MDM4 A > G, miR-27a A > G, miR-196a-2 C > T genes (

Indexed as

amplification refractory mutation system (ARMS)breast cancerKrüppel-like factor 14 genemicroRNA (miR-27amiR-196a)Mouse double minute 4 (MDM4) genesignaling pathway gene (PI3K-AKT)whole-exome sequencing (WES)

Identifiers

PMID36831624
PMCPMC9954638
OpenAlexW4321231568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.